Hepatitis refers to a disease of the liver that is inflammatory. Hepatitis is a medical condition in which the liver is mainly damaged and the digestive system and brain are further compromised in the long run. There are three primary forms of hepatitis: HAV, HBV, and HCV. HCV is a big public health issue where, due to inflammation, the liver gets inflamed.
Global Hepatitis Drug Market: Key Players
- F. Hoffmann-La Roche
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
- Gilead Sciences
- Johnson & Johnson
- Vertex Pharmaceuticals
- Achillion Pharmaceuticals
- Bristol-Myers Squibb
The worldwide rise in hepatitis prevalence is expected to fuel the growth of the demand for hepatitis drugs.
Global Hepatitis Drug Market: Segments
Global Hepatitis Drug Market is segmented by type into hepatitis A, B, C, and others. The greater market share in 2018 was accounted by hepatitis C segment and is expected to see the highest growth during the forecast period. A growing number of events involving various forms of hepatitis, including hepatitis B and hepatitis C, play an important role in driving the growth of the demand for hepatitis drugs. Hepatitis is recognized as a leading cause of mortality, while hepatitis C is responsible for around 500,000 deaths per year. The rise in the prevalence of hepatitis has also increased the overall demand for medications to cure and control the disease. Olysio and Sovaldi’s second generation DAAs are the key drivers of the hepatitis drug market. The DAAs of the second generation are more successful and have fewer adverse effects.
Global Hepatitis Drug Market: Market Dynamics
Prevalence of Hepatitis Infection
Infection with the hepatitis virus is one of the key global public health risks and is essentially a primary cause for the emergence of hepatic cirrhosis and hepatocellular carcinoma. The increasing number of infected populations, increased consumption of alcohol and narcotics, and improved access to medicinal products for hepatitis are also increasing.
High cost of Hepatitis Drug products
Factors such as longer development and approval periods for hepatitis drugs are expected to impede the growth of the demand for hepatitis drugs. As their production process is labour intensive and involves costly drug intermediates and active pharmaceutical ingredients, the manufacture of hepatitis drugs is extremely expensive.
Global Hepatitis Drug Market: Regions
Global Hepatitis Drug Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Global Hepatitis Drug Market in North America held the largest market share in the year 2018. The comparatively greater affordability of the patient population and knowledge of advanced therapeutics in the area was primarily due to the high demand in the U.S. Some of the main factors leading to this high proportion are the availability of well-developed healthcare facilities, insurance, and access to the most advanced medicines. During the forecast period, the Asia Pacific market is expected to see the fastest growth rate of 5.8 percent. The high burden of disease, increased access to drugs, improved healthcare & sanitation and increased awareness of hepatitis vaccination are expected to positively reinforce the growth prospects in the region.
Global Hepatitis Drug Market report also contains analysis on:
Global Hepatitis Drug Market Segments:
- Hepatitis A
- Hepatitis B
- Hepatitis C
By Route of Administration:
- Hepatitis Drug Market Dynamics
- Hepatitis Drug Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Table of Content
- Executive Summary
- Global Hepatitis Drug Market
- Research Methodology
- Average Pricing Analysis
- Macro-Economic Indicators
- Market Dynamics
- Correlation & Regression Analysis
- Recent Development, Policies & Regulatory Landscape
- Risk Analysis
- Global Hospital Beds Market Analysis
- Global Hepatitis Drug Market
- Global Hepatitis Drug Market: Market Segmentation
- Company Profile
Read Other Reports from our Database :
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Ph: +162 825 80070 (US)
Ph: +44 203 500 2763 (UK)